It’s often interesting to see and hear the things that go on at FDA advisory hearings, and the Feb. 18 hearing for leadless pacemakers proved to be no exception. I’ll admit at the outset that I’ve always been of the view that these advisory committee members are charged with making up their own minds about the questions the agency poses to the panel, but maybe I’m just naïve, yes? One of the questions the agency posed to the panel was whether a post-approval study for a leadless pacemaker could include patients who...

HONG KONG — At Chinese State Council meetings in February, Premier Li Keqiang emphasized the importance of innovation and upgrades to the health care sector, once again highlighting the importance of the pharmaceutical and medical device industries for China's next phase of development. Even as China's economy and international trade slows down, the med-tech sector continues to surge forward.